Tumors of the CNS: Practical Advances in the Care of Primary and Metastatic Brain Tumor Patients
Saturday, May 4, 2013
7:30 am – 4:50 pm
Dana-Farber Cancer Institute
Yawkey Center for Cancer Care
Boston, MA
Offered by Dana-Farber/Brigham and Women's Cancer Center, Massachusetts General Hospital Cancer Center and Harvard Medical School Department of Continuing Education
Quicklinks
Course Overview | Agenda | Faculty
Credits | Registration Information | Course Location
Course Overview
This course is designed to provide medical oncologists, neurologists, neurosurgeons, radiation oncologists, and other interested clinicians with clinically-relevant updates on the management of primary and metastatic brain tumors. Through lectures, case-based presentations and Q&A, participants will learn about emerging treatment strategies, technologic advances and supportive care interventions, as well as how to integrate these concepts in daily practice.
At the conclusion of this course, attendees will be able to: describe evolving treatment strategies and promising advances for newly diagnosed and recurrent primary and metastatic brain cancers; recognize technologic advances in neurosurgery, radiation therapy, neuroimaging and tumor analysis for brain tumors that impact care for brain tumors; and review supportive care and quality of life interventions for brain tumor patients.
This course has been designed to enhance the following Accreditation Council for Graduate Medical Education competencies: Patient care, Medical knowledge, Practice-based learning and improvement.
Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center
Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center
Agenda
7:30 am
Registration and Continental Breakfast
8:00 am
Welcome
David A. Reardon, MD
8:05 am
Advances in Malignant Glioma Biology
Rameen Beroukhim, MD, PhD
8:30 am
Advances in Neurosurgery
Alexandra Golby, MD
9:00 am
Advances in Radiation Therapy
Helen Shih, MD
9:30 am
Advances in Neuro-imaging
Elizabeth Gerstner, MD
10:00 am
Break
10:15 am
High-grade Glioma: Evolving Standard of Care
Andrew Chi, MD, PhD
10:45 am
High-grade Glioma: Future Therapeutic Directions
Patrick Y. Wen, MD
11:15 am
Case Presentation
Brian M. Alexander, MD; Ian F. Dunn, MD; David A. Reardon, MD
11:45 am
Neurofibromatosis Update
Scott Plotkin, MD, PhD
12:00 pm
Panel Discussion, Q&A
12:15 pm
Lunch
1:00 pm
Medical Management of Brain Tumor Patients
Jorg Dietrich, MD, PhD
1:30 pm
Primary Central Nervous System Lymphoma
Tracy Batchelor, MD, MPH
2:00 pm
Low-grade Tumors
Eric T. Wong, MD
2:30 pm
Brain Metastases
Eudocia Q. Lee, MD, MPH
3:00 pm
Break
3:15 pm
Neurologic Complications of Cancer Therapy
Lakshmi Nayak, MD
3:45 pm
Neuropsychologic Issues Among Brain Tumor Patients
Halyna L. Vitagliano, MD, MSci
4:15 pm
Case Presentations
Daniel P, Cahill, III, MD, PhD; Elizabeth Gerstner, MD; Jay Loeffler, MD
4:30 pm
Panel Discussion and Q&A
4:50 pm
Closing Remarks
David A. Reardon, MD
Faculty
David A. Reardon, MD, Course Co-Director
Clinical Director, Center for Neuro-Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School
Tracy Batchelor, MD, MPH, Course Co-Director
Executive Director, Center for Neuro-Oncology,
Massachusetts General Hospital Cancer Center;
Professor of Neurology, Harvard Medical School
Jay Loeffler, MD, Course Co-Director
Chief, Radiation Oncology, Massachusetts General Hospital Cancer Center;
Professor of Radiation Oncology, Harvard Medical School
Patrick Y. Wen, MD, Course Co-Director
Director, Center for Neuro-Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Neurology, Harvard Medical School
Brian M. Alexander, MD, MPH
Radiation Oncologist, Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Radiation Oncology, Harvard Medical School
Rameen Beroukhim, MD, PhD
Neuro-Oncologist, Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School
Daniel P. Cahill, III, MD, PhD
Neurosurgeon, Massachusetts General Hospital Cancer Center;
Assistant Professor of Surgery, Harvard Medical School
Andrew Chi, MD, PhD
Neuro-Oncologist, Massachusetts General Hospital Cancer Center;
Assistant Professor of Neurology, Harvard Medical School
Jorg Dietrich, MD, PhD
Neuro-Oncologist, Massachusetts General Hospital Cancer Center;
Assistant Professor of Neurology, Harvard Medical School
Ian F. Dunn, MD
Neurosurgeon, Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Surgery, Harvard Medical School
Elizabeth Gerstner, MD
Neuro-Oncologist, Massachusetts General Hospital Cancer Center;
Assistant Professor of Neurology, Harvard Medical School
Alexandra Golby, MD
Director of Image-Guided Neurosurgery,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Surgery and Associate Professor of Radiology, Harvard Medical School
Eudocia Q. Lee, MD, MPH
Neuro-Oncologist, Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Neurology, Harvard Medical School
Lakshmi Nayak, MD
Neuro-Oncologist, Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Neurology, Harvard Medical School
Scott Plotkin, MD, PhD
Director, Neurofibromatosis Clinic, Massachusetts General Hospital Cancer Center;
Associate Professor of Neurology, Harvard Medical School
Helen Shih, MD
Associate Medical Director, Proton Therapy Center, Massachusetts General Hospital Cancer Center;
Assistant Professor of Radiation Oncology, Harvard Medical School
Halyna L. Vitagliano, MD, MSci
Psychiatrist, Psychosocial Oncology, Dana-Farber/Brigham and Women's Cancer Center
Assistant Professor of Psychiatry, Harvard Medical School
Eric T. Wong, MD
Neuro-Oncologist, Beth Israel Deaconess Medical Center;
Associate Professor of Neurology, Harvard Medical School
Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
CME Credits
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.
The Harvard Medical School designates this live activity for a maximum of 7.5AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registration Information
Registration Fee: $75.00
Registration fee includes course materials, continental breakfast, lunch, and complimentary parking.
To register by mail: please send a completed registration form and payment by April 25, 2013:
Neuro-Oncology CME
Dana-Farber Cancer Institute
Attn: Kamira Wooten
450 Brookline Avenue, OS 381
Boston, MA 02215
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call 800-553-3787.
Course Location
This course will be held at Dana-Farber’s Yawkey Center for Cancer Care in the Yawkey Conference Center, located on the 3rd floor, 450 Brookline Avenue, Boston, MA. Complimentary parking is available in the Dana-Farber garage located on Jimmy Fund Way. For directions, visit www.dana-farber.org/directions.
